48 results on '"de Rond, Lia"'
Search Results
2. Cytomegalovirus and Epstein–Barr virus co-infected young and middle-aged adults can have an aging-related T-cell phenotype
3. Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study
4. Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status
5. Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study
6. Contribution of SARS-CoV-2 infection preceding COVID-19 mRNA vaccination to generation of cellular and humoral immune responses in children
7. Determinants of antibody responses after vaccination against SARS-CoV-2 in older persons. The Doetinchem Cohort Study
8. Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization
9. In-depth immune cellular profiling reveals sex-specific associations with frailty
10. Contribution of SARS-CoV-2 infection preceding COVID-19 mRNA vaccination to generation of cellular and humoral immune responses in children.
11. Both Cytomegalovirus and Epstein-Barr virus infections affect quantities of circulating T- cells and combined they result in an aging-related T-cell phenotype at younger age
12. Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study
13. Reduced Antibody Acquisition with Increasing Age following Vaccination with BNT162b2: Results from Two Longitudinal Cohort Studies in The Netherlands
14. Characterization of the early cellular immune response induced by HPV vaccines
15. Reduced antibody acquisition with increasing age following vaccination with BNT162b2: results from a large study performed in the general population aged 12 to 92 years
16. Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination
17. Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.
18. Limited effect of duration of CMV infection on adaptive immunity and frailty: insights from a 27-year-long longitudinal study
19. In-depth immune cellular profiling reveals sex-specific associations with frailty
20. Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults
21. Elevated Immune Response Among Children 4 Years Of Age With Pronounced Local Adverse Events After The Fifth Dtap Vaccination
22. Elevated Immune Response Among Children 4 Years Of Age With Pronounced Local Adverse Events After The Fifth Dtap Vaccination
23. Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults
24. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females
25. Identification of pertussis-specific effector memory T cells in preschool children
26. Identification of pertussis-specific effector memory T cells in preschool children
27. Identification of pertussis-specific effector memory T cells in preschool children
28. Identification of Pertussis-Specific Effector Memory T Cells in Preschool Children
29. Differences in CD4 and CD8 memory T-cell populations in Dutch children after vaccination with various pertussis vaccines.
30. Evaluation of Bordetella pertussis-specific immune responses after infection or after different vaccination programs in the framework of the FP7 Child-INNOVAC program.
31. Differential T- and B-Cell Responses to Pertussis in Acellular Vaccine-Primed versus Whole-Cell Vaccine-Primed Children 2 Years after Preschool Acellular Booster Vaccination
32. T-Cell Responses before and after the Fifth Consecutive Acellular Pertussis Vaccination in 4-Year-Old Dutch Children
33. Pertussis Circulation Has Increased T-Cell Immunity during Childhood More than a Second Acellular Booster Vaccination in Dutch Children 9 Years of Age
34. Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age
35. Serum IgA Responses against Pertussis Proteins in Infected and Dutch wP or aP Vaccinated Children: An Additional Role in Pertussis Diagnostics
36. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children
37. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age
38. Systemic Signature of the Lung Response to Respiratory Syncytial Virus Infection
39. Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins
40. Gene Expression Differences in Lungs of Mice during Secondary Immune Responses to Respiratory Syncytial Virus Infection
41. Host Transcription Profiles upon Primary Respiratory Syncytial Virus Infection
42. Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-?
43. Effect of lack of Interleukin-4, Interleukin-12, Interleukin-18, or the Interferon-? receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice
44. Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-γ.
45. Effect of lack of Interleukin-4, Interleukin-12, Interleukin-18, or the Interferon-γ receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice.
46. Limited effect of duration of CMV infection on adaptive immunity and frailty: insights from a 27-year-long longitudinal study.
47. Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-gamma.
48. Effect of lack of Interleukin-4, Interleukin-12, Interleukin-18, or the Interferon-gamma receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.